Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05704764 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances

Study acronym: IRIS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 20, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 4 of 4 entriesv5
  2. Primary endpoints revised (2)v4 Show 4 more changesShow less
    • Secondary endpoints: 2 to 4
    • Study description shortened, about 20 words
    • Study sites revised (2)
    • Eligibility criteria shortened, about 3 words
  3. Primary completion date: Sep 30, 2025 to Mar 31, 2026
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Study completion date: Dec 31, 2025 to Jun 30, 2026
    v3
  4. Start date: Jan 18, 2023 to Feb 17, 2023
    • Primary completion date: Aug 31, 2025 to Sep 30, 2025
    • Study completion date: Aug 31, 2025 to Dec 31, 2025
    • Collaborators revised (3)
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to test an intervention to reduce stigma among people living with HIV who use opioids and cocaine. The main question it aims to answer is: \- Does reducing internalized stigma about HIV and/or drug use lead to improved HIV care outcomes? After a year spent adapting an existing intervention to be applied specifically among people living with HIV who use substances, 70 participants will be randomized to receive either treatment-as-usual or the newly adapted intervention. The intervention itself will consist of five one-on-one sessions with a trained interventionist to discuss and work through the stigmas people commonly associate with HIV and/or substance use.
Trial Details
NCT Number NCT05704764
Lead Sponsor Friends Research Institute, Inc.
Collaborators: University of Maryland, National Institute on Drug Abuse (NIDA), Johns Hopkins University
Conditions
(from sponsor)		 HIV, Stigma, Social, Substance Use
Related terms Social Stigma, Substance-Related Disorders
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov